Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses
PI Siafaka, N Üstündağ Okur, E Karavas… - International journal of …, 2016 - mdpi.com
Nanocarriers, due to their unique features, are of increased interest among researchers
working with pharmaceutical formulations. Polymeric nanoparticles and nanocapsules …
working with pharmaceutical formulations. Polymeric nanoparticles and nanocapsules …
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
R Ranganathan, S Madanmohan… - International journal …, 2012 - Taylor & Francis
The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the
serious side effects caused by anticancer agents as a result of their cytotoxic actions on …
serious side effects caused by anticancer agents as a result of their cytotoxic actions on …
Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes
P Panwar, B Pandey, PC Lakhera… - International journal of …, 2010 - Taylor & Francis
The purpose of the present study was to formulate effective and controlled release
albendazole liposomal formulations. Albendazole, a hydrophobic drug used for the …
albendazole liposomal formulations. Albendazole, a hydrophobic drug used for the …
Advances in PEGylation of important biotech molecules: delivery aspects
SM Ryan, G Mantovani, X Wang… - Expert opinion on …, 2008 - Taylor & Francis
Background: Although various injected peptide and protein therapeutics have been
developed successfully over the past 25 years, several pharmacokinetic and immunological …
developed successfully over the past 25 years, several pharmacokinetic and immunological …
Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug
OB Garbuzenko, M Saad, S Betigeri, M Zhang… - Pharmaceutical …, 2009 - Springer
Purpose To compare systemic intravenous and local intratracheal delivery of doxorubicin
(DOX), antisense oligonucleotides (ASO) and small interfering RNA (siRNA). Methods …
(DOX), antisense oligonucleotides (ASO) and small interfering RNA (siRNA). Methods …
Recent advances in protection against doxorubicin-induced toxicity
R Injac, B Strukelj - Technology in cancer research & …, 2008 - journals.sagepub.com
Anthracycline antibiotics are among the most effective and commonly used anticancer
drugs. Unfortunately, their clinical use is restricted by dose-dependent toxicity. Doxorubicin …
drugs. Unfortunately, their clinical use is restricted by dose-dependent toxicity. Doxorubicin …
Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker
LM Kaminskas, BD Kelly, VM McLeod, G Sberna… - Journal of controlled …, 2011 - Elsevier
Polylysine dendrimers have potential as biodegradable vectors for the delivery of cytotoxic
drugs to solid tumours. Here, the cytotoxicity, drug release and tumour targeting properties of …
drugs to solid tumours. Here, the cytotoxicity, drug release and tumour targeting properties of …
Vasodilator hydralazine promotes nanoparticle penetration in advanced desmoplastic tumors
Desmoplastic tumors are normally resistant to nanoparticle-based chemotherapy due to
dense stroma and limited particle permeability inside the tumor. Herein, we reported that …
dense stroma and limited particle permeability inside the tumor. Herein, we reported that …
MT1‐MMP‐Activated liposomes to improve tumor blood perfusion and drug delivery for enhanced pancreatic cancer therapy
Y Wei, S Song, N Duan, F Wang, Y Wang… - Advanced …, 2020 - Wiley Online Library
Promoting tumor angiogenesis effectively and specifically to resolve tumor‐associated
hypoperfusion holds promise for improving pancreatic cancer therapy. Herein, a doxorubicin …
hypoperfusion holds promise for improving pancreatic cancer therapy. Herein, a doxorubicin …
Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances
J Buse, A El-Aneed - Nanomedicine, 2010 - Taylor & Francis
Lipid-based drug-delivery systems have evolved from micro-to nano-scale, enhancing the
efficacy and therapeutic applications of these delivery systems. Production of lipid-based …
efficacy and therapeutic applications of these delivery systems. Production of lipid-based …